$157 Million is the total value of JW Asset Management, LLC's 20 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EGRX | EAGLE PHARMACEUTICALS INC | $35,996,000 | +43.6% | 475,755 | 0.0% | 22.95% | -7.1% | |
| AMZN | AMAZON COM INC | $33,362,000 | +17.4% | 19,627 | 0.0% | 21.27% | -24.0% | |
| CRON | CRONOS GROUP INC | $7,247,000 | -3.1% | 1,111,444 | 0.0% | 4.62% | -37.3% | |
| HZNP | HORIZON PHARMA PLC | $4,484,000 | +16.6% | 270,775 | 0.0% | 2.86% | -24.6% | |
| MSFT | MICROSOFT CORP | $4,092,000 | +8.0% | 41,500 | 0.0% | 2.61% | -30.1% | |
| PETQ | PETIQ INC | $3,998,000 | +1.0% | 148,855 | 0.0% | 2.55% | -34.7% | |
| JNP | JUNIPER PHARMACEUTICALS INC | $3,714,000 | -14.3% | 426,903 | 0.0% | 2.37% | -44.5% | |
| BSTC | BIOSPECIFICS TECHNOLOGIES CO | $3,304,000 | +1.2% | 73,649 | 0.0% | 2.11% | -34.6% | |
| BABA | ALIBABA GROUP HLDG LTDsponsored ads | $3,293,000 | +1.1% | 17,750 | 0.0% | 2.10% | -34.6% | |
| LGND | LIGAND PHARMACEUTICALS INC | $2,776,000 | +25.4% | 13,401 | 0.0% | 1.77% | -18.8% | |
| AVDL | AVADEL PHARMACEUTICALS PLCsponsored adr | $2,724,000 | -15.9% | 444,439 | 0.0% | 1.74% | -45.6% | |
| MU | MICRON TECHNOLOGY INC | $2,150,000 | +0.6% | 41,000 | 0.0% | 1.37% | -34.9% | |
| NVLNF | NOVELION THERAPEUTICS INC | $1,163,000 | +5.2% | 315,979 | 0.0% | 0.74% | -32.0% | |
| OSTK | OVERSTOCK COM INC DEL | $337,000 | -7.2% | 10,000 | 0.0% | 0.22% | -39.9% | |
| SNOA | SONOMA PHARMACEUTICALS INC | $102,000 | -32.5% | 40,951 | 0.0% | 0.06% | -56.4% | |
| TLGT | TELIGENT INC NEW | $48,000 | +4.3% | 13,820 | 0.0% | 0.03% | -31.1% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-10
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMAZON COM INC COM | 30 | Q1 2022 | 44.1% |
| ESTABLISHMENT LABS HLDGS INC | 24 | Q2 2024 | 92.3% |
| ANTARES PHARMA INC | 19 | Q2 2019 | 4.0% |
| EAGLE PHARMACEUTICALS INC | 18 | Q1 2019 | 28.4% |
| HORIZON PHARMA PLC | 18 | Q1 2019 | 8.2% |
| HORIZON THERAPEUTICS PUB LTD | 17 | Q2 2023 | 6.5% |
| LIGAND PHARMACEUTICALS INC SHS CL B | 17 | Q4 2018 | 3.4% |
| BIOSPECIFICS TECHNOLOGIES CO | 16 | Q1 2019 | 8.4% |
| MICROSOFT CORP | 14 | Q1 2020 | 11.1% |
| CAMBREX CORP COM | 14 | Q1 2018 | 2.6% |
View JW Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| TerrAscend Corp. | January 02, 2024 | 57,621,892 | 20.1% |
| ESTABLISHMENT LABS HOLDINGS INC. | May 30, 2019 | 2,320,364 | 11.4% |
| EAGLE PHARMACEUTICALS, INC. | January 27, 2017 | 397,648 | 2.6% |
View JW Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-11-08 |
| 4 | 2024-09-16 |
| N-PX | 2024-08-26 |
| 13F-HR | 2024-08-08 |
| 4 | 2024-06-20 |
| 13F-HR | 2024-05-07 |
| 13F-HR | 2024-02-09 |
| 4 | 2024-01-02 |
| SC 13D/A | 2024-01-02 |
| 4 | 2023-12-26 |
View JW Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.